Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525

Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free
free
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=19071062&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
  English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |   
lüll Possible novel targets for therapeutic angiogenesis Cristofaro B; Emanueli CCurr Opin Pharmacol 2009[Apr]; 9 (2): 102-8An increasing number of studies about the molecular basis of angiogenesis are rapidly disclosing novel signal pathways involved in the blood vessel formation process. This review will focus on bone morphogenic proteins, Hedgehog, Notch, ephrins, neuropilins, neurotrophins and netrins. These recently discovered angiogenesis mediators are involved in vascular development during embryogenesis and, interestingly, they are shared between the nervous and vascular systems. They represent new potential targets in the vasculature and suggest novel therapeutic opportunities.|Angiogenesis Inhibitors/*therapeutic use[MESH]|Animals[MESH]|Bone Morphogenetic Proteins/physiology[MESH]|Drug Delivery Systems[MESH]|Ephrins/physiology[MESH]|Hedgehog Proteins/physiology[MESH]|Humans[MESH]|Neovascularization, Pathologic/*drug therapy[MESH]|Neovascularization, Physiologic/*physiology[MESH]|Nerve Growth Factors/physiology[MESH]|Netrin-1[MESH]|Neuropilins/physiology[MESH]|Receptors, Eph Family/physiology[MESH]|Receptors, Notch/physiology[MESH]|Tumor Suppressor Proteins/physiology[MESH] |